A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

Clinical trial NCT02366962 · COMPLETED

Trial details

NCT number: NCT02366962
Sponsor: UMN Pharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Vaccine

Start date: 2015-02-01
Primary completion: 2015-04-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.